Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 3
Submit an article Journal homepage
365
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Myelodysplastic syndromes (MDS) occurring in Agent Orange exposed individuals carry a mutational spectrum similar to that of de novo MDS

Adam S. SperlingDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; ;Broad Institute of MIT and Harvard, Cambridge, MA, USAView further author information
,
Matthew LeventhalBroad Institute of MIT and Harvard, Cambridge, MA, USAView further author information
,
Christopher J. GibsonDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; View further author information
,
Benjamin L. EbertDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; ;Broad Institute of MIT and Harvard, Cambridge, MA, USAView further author information
&
David P. SteensmaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Correspondence[email protected]
View further author information
Pages 728-731 | Received 31 Aug 2019, Accepted 28 Oct 2019, Published online: 12 Nov 2019

References

  • Sperling AS, Gibson CJ, Ebert BL. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer. 2017;17(1):5–19.
  • Ma X. Epidemiology of myelodysplastic syndromes. Am J Med. 2012;125(7):S2–S5.
  • National Academies of Sciences, Engineering, and Medicine. Veterans and Agent Orange: Update 11 2018. Washington (DC)2018.
  • Chamie K, DeVere White RW, Lee D, et al. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer. 2008;113(9):2464–2470.
  • Kramarova E, Kogevinas M, Anh CT, et al. Exposure to Agent Orange and occurrence of soft-tissue sarcomas or non-Hodgkin lymphomas: an ongoing study in Vietnam. Environ Health Perspect. 1998;106 (Suppl 2):671–678.
  • Landgren O, Shim YK, Michalek J, et al. Agent orange exposure and monoclonal gammopathy of undetermined significance: An Operation Ranch Hand Veteran Cohort Study. JAMA Oncol. 2015;1(8):1061–1068.
  • Fracchiolla NS, Annaloro C, Guidotti F, et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) role in hematopoiesis and in hematologic diseases: a critical review. Toxicology. 2016;374:60–68.
  • Iwanaga M, Hsu WL, Soda M, et al. Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors. JCO. 2011;29(4):428–434.
  • Department of Veterans Affairs. Agent Orange. Department of Veterans Affairs, 2018. 2018. Available from: https://www.publichealth.va.gov/exposures/agentorange/index.asp
  • Kluk MJ, Lindsley RC, Aster JC, et al. Validation and implementation of a custom next-generation sequencing clinical assay for hematologic malignancies. J Mol Diagn. 2016;18(4):507–515.
  • Frank K, Aster JC, Lindsley C. Two-year experience of performing a next-generation-sequencing based panel test in an academic medical center and its clinical impact. Blood. 2016;128(22):1707.
  • Jaiswal S, Natarajan P, Silver AJ, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2):111–121.
  • Lindsley RC, Saber W, Mar BG, et al. Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation. N Engl J Med. 2017;376(6):536–547.
  • Makishima H, Yoshizato T, Yoshida K, et al. Dynamics of clonal evolution in myelodysplastic syndromes. Nat Genet. 2017;49(2):204–212.
  • Kolluri SK, Jin UH, Safe S. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target. Arch Toxicol. 2017;91(7):2497–2513.
  • Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415–421.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.